会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 87. 发明授权
    • Human endothelin-bombesin receptor antibodies
    • 人内皮素 - 铃蟾肽受体抗体
    • US06518404B1
    • 2003-02-11
    • US09520210
    • 2000-03-07
    • Yi LiCraig A. RosenChandrika Kumar
    • Yi LiCraig A. RosenChandrika Kumar
    • C07K1628
    • C07K14/70571A61K38/00C07K14/72C07K14/723C12N2799/026
    • A human endothelin-bombesin receptor polypeptide and DNA (RNA) encoding such polypeptide and a procedure for disclosed. Also disclosed are methods for utilizing such polypeptide for identifying agonists and antagonists to such polypeptide. Agonists to the endothelin-bombesin receptor polypeptide of the present invention may be used to treat asthma, Parkinson's Disease, acute heart failure, hypotension and osteoporosis. Antagonists against such polypeptides may be used therapeutically to treat hypertension, ulcerigenesis, subarachnoid hemorrhage, asthma, tumors, ciclosporin toxicity, cancer and septic shock. Also disclosed are diagnostic methods for detecting mutations in the polynucleotides of the present invention and for detecting levels of the soluble polypeptides in samples derived from a host.
    • 人内皮素 - 铃蟾肽受体多肽和编码这种多肽的DNA(RNA)和用于公开的方法。 还公开了利用这种多肽识别这种多肽的激动剂和拮抗剂的方法。 本发明的内皮素 - 铃蟾肽受体多肽的激动剂可用于治疗哮喘,帕金森病,急性心力衰竭,低血压和骨质疏松症。 抗这种多肽的拮抗剂可以治疗性地用于治疗高血压,溃疡发生,蛛网膜下腔出血,哮喘,肿瘤,环孢菌素毒性,癌症和败血性休克。 还公开了用于检测本发明的多核苷酸中的突变并用于检测衍生自宿主的样品中可溶性多肽的水平的诊断方法。